Information Journal Paper
APA:
Copy. (2018). Empagliflozin treatment is associated with improved β-cell function in type 2 diabetes mellitus. JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, 103(4), 1402-1407. SID. https://sid.ir/paper/694681/en
Vancouver:
Copy. Empagliflozin treatment is associated with improved β-cell function in type 2 diabetes mellitus. JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM[Internet]. 2018;103(4):1402-1407. Available from: https://sid.ir/paper/694681/en
IEEE:
Copy, “Empagliflozin treatment is associated with improved β-cell function in type 2 diabetes mellitus,” JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, vol. 103, no. 4, pp. 1402–1407, 2018, [Online]. Available: https://sid.ir/paper/694681/en